Determinants affecting initiation of continuous positive airway pressure treatment

Israel Medical Association Journal

Volumn 7, Issue 1, 2005, Pages 13-18

  Brin, Yaron S ^a   Reuveni, Haim ^a   Greenberg, Sari ^a   Tal, Asher ^a   Tarasiuk, Ariel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Co payment; Continuous positive airway pressure; Obstructive sleep apnea syndrome; Patient support; Socioeconomic status

Indexed keywords

ADAPTATION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; COST CONTROL; DEVICE; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DOCTOR PATIENT RELATION; ENVIRONMENTAL FACTOR; EPWORTH SLEEPINESS SCALE; FEMALE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HUMAN; INCOME; LABORATORY PERSONNEL; LOGISTIC REGRESSION ANALYSIS; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MARKETING; MEDICAL FEE; POSITIVE END EXPIRATORY PRESSURE; QUESTIONNAIRE; RESPIRATORY FAILURE; RISK ASSESSMENT; SCORING SYSTEM; SLEEP APNEA SYNDROME; SOCIAL STATUS; SOCIAL SUPPORT; SOMNOLENCE; TITRIMETRY; TREATMENT INDICATION;

CONTINUOUS POSITIVE AIRWAY PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH EXPENDITURES; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERPERSONAL RELATIONS; ISRAEL; LOGISTIC MODELS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; POLYSOMNOGRAPHY; RETROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; SOCIOECONOMIC FACTORS;

EID: 12344282656     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-39.
2. Lavie P. Treatment of sleep apnea: unmet needs. Chest 1999;116:1501-3.
3. Hui DS, Choy DKL, Li TST, et al. Determinants of continuous positive airway pressure compliance in a group of Chinese patients with obstructive sleep apnea. Chest 2001;120:170-6.
4. Sin DD, Mayers I, Man GC, Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest 2002;121:430-5.
5. Whittle AT, Douglas NJ. Does the physiological success of CPAP titration predict clinical success? J Sleep Res 2000;9:201-6.
6. Massie CA, Hart RW. Clinical outcomes related to interface type in patients with obstructive sleep apnea/hypopnea syndrome who are using continuous positive airway pressure. Chest 2003;123:1112-18.
7. Waldhorn RE, Herrick TW, Nguyen MC, O'Donnell AE, Sodero J, Potolicchio SJ. Long term compliance with nasal continuous positive airway pressure therapy of obstructive sleep apnea. Chest 1990;97:33-8.
8. Likar LL, Panciera TM, Erickson AD, Rounds S. Group education sessions and compliance with nasal CPAP therapy. Chest 1997;111:1273-7.
9. Hoy CJ, Vennelle M, Kingshott RN, Engleman HM, Douglas NJ. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med 1999;159:1096-100.
10. Popescu G, Latham M, Allgar V, Elliott MW. Continuous positive airway pressure for sleep apnea/hypopnoea syndrome: usefulness of a 2-week trial to identify factors associated with long term use. Thorax 2001;56:727-33.
11. Hui DS, Chan JKW, Choy DKL, et al. Effects of augmented continuous positive airway pressure education and support on compliance and outcome in a Chinese population. Chest 2000;117:1410-16.
12. Namen AM, Dunagan DP, Fleischer A, et al. increased physician-reported sleep apnea: the National Ambulatory Medical Care Survey. Chest 2002;121:1741-7.
13. Reuveni H, Sheizaf B, Elhayany A, et al. The effect of drug co-payment policy on the purchase of prescription drugs for children with infections in the community. Health Policy 2002;62:1-13.
14. Krieger J, Kurtz D, Petiau C, Sforza E, Trautmann D. Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers. Sleep 1996;19:S136-43.
15. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-54.
16. Statistical abstract of Israel. No 53. Tables 12 and 37. Jerusalem: Central Bureau of Statistics., 2002.
17. Rotem AY, Sperber AD, Krugliak P, Freidman B, Tal A, Tarasiuk A. Polysomnography and actigraphy evidence of sleep fragmentation in irritable bowel syndrome. Sleep 2003;26:746-52.
18. McArdle N, Devereux G, Heidarnejad H, Engleman HM, Mackay TW, Douglas NJ. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:1108-14.
19. Rauscher H, Popp W, Wanke T, Zwick H. Acceptance of CPAP therapy for sleep apnea. Chest 1991;100:1019-23.
20. McArdle N, Kingshott R, Engleman HM, Mackay TW, Douglas NJ. Partners of patients with sleep apnoea/hypopnoea syndrome: effect of CPAP treatment on sleep quality and quality of life. Thorax 2001;56:513-18.
21. Rauscher H, Formanek D, Popp W, Zwick H. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest 1993;103:1675-80.
22. Weaver TE, Maislin G, Dinges DF, et al. Self-efficacy in sleep apnea: instrument development and patient perceptions of obstructive sleep apnea risk, treatment benefit, and volition to use continuous positive airway pressure. Sleep 2003;26:727-32.
23. Soumerai SB, Ross-Degnan D, Fortess EE, Abelson J. A critical analysis of studies of state drug reimbursement policies: research in need of discipline. Milbank Q 1993;71:217-52.
24. Becker MH, Maiman LA. Sociobehavioral determinants of compliance with health and medical care recommendations. Med Care 1975;13:10-24.